{
    "title": "107_s1661",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Deadly Biological Agent Control Act \nof 2001''.\n\nSEC. 2. BIOLOGICAL WEAPONS.\n\n    (a) Select Agents.--Section 175 of title 18, United States Code, is \namended by striking subsection (b) and inserting the following:\n    ``(b) Select Agents.--\n            ``(1) Uncertified possession.--Whoever knowingly possesses \n        a select agent without obtaining a certification from the \n        Department of Health and Human Services under section 511(f) of \n        the Antiterrorism and Effective Death Penalty Act of 1996, \n        shall be fined under this title, imprisoned for not more than 5 \n        years, or both.\n            ``(2) Transfer to uncertified person.--Any research \n        facility that knowingly transfers a select agent to an entity \n        that has not obtained a certification from the Department of \n        Health and Human Services under section 511(f) of the \n        Antiterrorism and Effective Death Penalty Act of 1996, shall be \n        fined under this title, imprisoned for not more than 5 years, \n        or both.\n    ``(c) Definitions.--In this section:\n            ``(1) Biological agent; toxin.--The terms `biological \n        agent' and `toxin' have the same meanings given those terms in \n        section 178, except that, for purposes of subsection (b), if \n        the biological agent or toxin has not been cultivated, \n        cultured, collected, or otherwise extracted from its natural \n        source, those terms do not include any biological agent or \n        toxin that is in its naturally occurring environment.\n            ``(2) For use as a weapon.--The term `for use as a weapon' \n        includes the development, production, transfer, acquisition, \n        retention, or possession of any biological agent, toxin, or \n        delivery system, other than for prophylactic, protective, or \n        other peaceful purposes.\n            ``(3) Select agent.--The term `select agent' means a \n        biological agent or toxin that--\n                    ``(A) is included on the list established under \n                section 511(d)(1) of the Antiterrorism and Effective \n                Death Penalty Act of 1996; and\n                    ``(B) is not possessed by a health, research, or \n                other entity listed under subparagraph (C) or (D) of \n                section 511(f)(2) of that Act.''.\n    (b) List of Biological Toxins.--Section 511(d) of the Antiterrorism \nand Effective Death Penalty Act of 1996 (42 U.S.C. 262 note) is amended \nto read as follows:\n    ``(d) Regulatory Control of Biological Agents.--\n            ``(1) List of biological agents and toxins.--The Secretary, \n        in consultation with the Secretary of Defense, Attorney \n        General, and other appropriate Federal officials, shall--\n                    ``(A) annually review the existing list of select \n                agents; and\n                    ``(B) if necessary, revise that existing list of \n                select agents.\n            ``(2) Criteria.--In determining whether to include a \n        biological agent or toxin on the list established under \n        paragraph (1), the Secretary shall--\n                    ``(A) consider--\n                            ``(i) the effect on human health of \n                        exposure to each biological agent or toxin;\n                            ``(ii) the degree of contagiousness of each \n                        biological agent or toxin and the methods by \n                        which each biological agent or toxin is \n                        transferred to humans;\n                            ``(iii) the availability and effectiveness \n                        of vaccines and therapies to treat or prevent \n                        any illness resulting from infection by or \n                        exposure to each biological agent or toxin;\n                            ``(iv) the potential use of each biological \n                        agent or toxin in a bioterrorist attack on the \n                        civilian population; and\n                            ``(v) any other criteria that the Secretary \n                        considers appropriate; and\n                    ``(B) consult with scientific experts who represent \n                appropriate professional groups.\n            ``(3) Prioritization of countermeasures.--The Secretary \n        shall prioritize countermeasures, including vaccines, \n        therapies, medical devices, and diagnostic tests which must be \n        developed, produced, or obtained in preparation for a \n        bioterrorist attack or other significant disease emergency in \n        order to treat, prevent, or identify infection by, or exposure \n        to, biological agents and toxins, listed pursuant to this \n        subsection.''.\n    (c) Regulation of Possession of Biological Agents and Toxins.--\nSection 511(f) of the Antiterrorism and Effective Death Penalty Act of \n1996 (42 U.S.C. 262 note) is amended to read as follows:\n    ``(f) Possession and Use of Listed Biological Agents and Toxins.--\n            ``(1) Standards and procedures.--The Secretary shall \n        provide for the establishment and enforcement of standards and \n        procedures governing the possession and use of biological \n        agents and toxins listed pursuant to subsection (d)(1), in \n        order to protect the health and safety of the public, including \n        safeguards to prevent access to those biological agents and \n        toxins for use in domestic or international terrorism, or for \n        any other criminal purpose.\n            ``(2) Certification.--\n                    ``(A) In general.--The Secretary shall establish a \n                certification process for the possession and use of \n                biological agents and toxins listed pursuant to \n                subsection (d)(1).\n                    ``(B) Possession.--Except as provided in \n                subparagraph (C), the certification process established \n                under subparagraph (A) shall prohibit any individual \n                from knowingly possessing biological agents or toxins \n                listed pursuant to subsection (d)(1).\n                    ``(C) Exception.--A health, research, or other \n                entity may possess a biological toxin or agent listed \n                pursuant to subsection (d)(1), if that entity is \n                described in subparagraph (D) or (E).\n                    ``(D) Legitimate purpose.--A health, research, or \n                other entity is described in this subparagraph, if--\n                            ``(i) the health, research, or other entity \n                        is certified as legitimate by the Department of \n                        Health and Human Services;\n                            ``(ii) the research facility has a \n                        legitimate research or other peaceful purpose \n                        for possessing the biological agent or toxin;\n                            ``(iii) the research facility submits to \n                        periodic site inspections; and\n                            ``(iv) the health, research, or other \n                        entity demonstrates the establishment and \n                        enforcement of safety procedures for the \n                        possession of biological agents or toxins \n                        listed pursuant to subsection (d), including \n                        measures to ensure--\n                                    ``(I) proper training and \n                                appropriate skills for handling the \n                                biological agents and toxins;\n                                    ``(II) proper laboratory facilities \n                                to contain and dispose of the \n                                biological agents and toxins; and\n                                    ``(III) safeguards to prevent \n                                access to the biological agents and \n                                toxins for use in domestic or \n                                international terrorism, or for any \n                                other criminal purpose.\n                    ``(E) Diagnostic or verification purpose.--A \n                health, research, or other entity is described in this \n                subparagraph, if the entity--\n                            ``(i) possesses the biological agent or \n                        toxin as part of a clinical specimen intended \n                        for diagnostic or verification purposes;\n                            ``(ii) transfers the biological agent or \n                        toxin to another entity that is certified under \n                        this subsection, or disposes of the biological \n                        agent or toxin within 72 hours in accordance \n                        with section 72.6(i) of title 42, Code of \n                        Federal Regulations; and\n                            ``(iii) reports the presence of the \n                        biological agent or toxin to the Centers for \n                        Disease Control.\n            ``(3) Research facilities.--\n                    ``(A) In general.--Any individual who handles \n                biological agents or toxins in an entity certified \n                under this subsection shall--\n                            ``(i) pass a criminal background check, \n                        which shall include a determination of whether \n                        that individual is a restricted person (as that \n                        term is defined in section 175b of title 18, \n                        United States Code); and\n                            ``(ii) be registered with the Department of \n                        Health and Human Services for  the specific \nresearch project that requires the use of biological agents or toxins.\n                    ``(B) Penalties.--\n                            ``(i) Research facilities.--Any entity that \n                        is certified under this subsection and permits \n                        a restricted person, as that term is defined in \n                        section 175b of title 18, United States Code, \n                        to handle or access biological agents or toxins \n                        may be subject to decertification by the \n                        Department of Health and Human Services and \n                        civil penalties in an amount not to exceed \n                        $500,000.\n                            ``(ii) Supervisory personnel.--Supervisory \n                        personnel in an entity that is certified under \n                        this subsection, who knowingly permit a \n                        restricted person, as that term is defined in \n                        section 175b of title 18, United States Code, \n                        to handle or access biological agents or toxins \n                        shall be subject to civil penalties in an \n                        amount not to exceed $250,000 and shall be \n                        imprisoned for not more than 1 year.''.\n    (d) Civil Penalties.--Section 511 of the Antiterrorism and \nEffective Death Penalty Act of 1996 (42 U.S.C. 262 note) is amended \nby--\n            (1) redesignating subsection (g) as subsection (h); and\n            (2) inserting after subsection (f) the following:\n    ``(g) Civil Penalty.--A person who violates subsection (e) or (f) \nshall be subject to the United States for a civil penalty in an amount \nnot to exceed $250,000 in the case of an individual and $500,000 in the \ncase of an entity certified under subsection (f).''.\n    (e) Section 511.--\n            (1) In general.--Section 511 of the Antiterrorism and \n        Effective Death Penalty Act of 1996 (42 U.S.C 262 note) is \n        amended--\n                    (A) in subsection (e)--\n                            (i) by inserting ``and toxins'' after \n                        ``agents'' each place that term appears; and\n                            (ii) by inserting ``or toxin'' after \n                        ``agent'' each place that term appears; and\n                    (B) in subsection (h)(1), as redesignated by this \n                Act, by striking ``the term `biological agent' has'' \n                and inserting ``the terms `biological agent' and \n                `toxin' have''.\n            (2) Effective date.--The amendments made by this subsection \n        shall be deemed to have the same effective date as section 511 \n        of the Antiterrorism and Effective Death Penalty Act of 1996 \n        (42 U.S.C. 262 note).\n    (f) Conforming Amendments.--Section 511(e) of the Antiterrorism and \nEffective Death Penalty Act of 1996 (42 U.S.C. 262 note) is amended--\n            (1) in the matter preceding paragraph (1), by striking ``, \n        through regulation promulgated under subsection (f),''; and\n            (2) in the heading, by striking ``Agents'' and inserting \n        ``Agents and Toxins''.\n\nSEC. 3. INTERIM RULE.\n\n    (a) In General.--Not later than 30 days after the date of enactment \nof this Act, the Secretary of Health and Human Services shall \npromulgate an interim final rule for carrying out section 511(d) of the \nAntiterrorism and Effective Death Penalty Act of 1996 (42 U.S.C. 262 \nnote), as amended by this Act.\n    (b) Effective Date.--The interim final rule promulgated under \nsubsection (a) shall take effect 60 days after the date on which the \nrule is promulgated, including for purposes of--\n            (1) section 175(b)(1) of title 18, United States Code \n        (relating to criminal penalties), as added by this Act; and\n            (2) section 511(g) of the Antiterrorism and Effective Death \n        Penalty Act of 1996 (relating to civil penalties), as added by \n        this Act.\n\nSEC. 4. REGISTRATION OF BIOLOGICAL AGENTS AND TOXINS.\n\n    In the case of a research facility that, as of the date of \nenactment of this Act, is in possession of a biological agent or toxin \nthat is listed pursuant to section 511(d) of the Antiterrorism and \nEffective Death Penalty Act of 1996, as amended by this Act, that \nresearch facility shall, in accordance with the interim final rule \npromulgated under section 3, submit an application for certification \nunder section 511(f) of the Antiterrorism and Effective Death Penalty \nAct of 1996, not later than 30 days after the date on which the rule is \npromulgated."
}